Sundar PichaiSundar Pichai earned $164M in 2023

CEO of Apellis Pharmaceuticals, Inc.

Quick Links
A

Adam Townsend

CEO of Apellis Pharmaceuticals, Inc.

Education

Medical biochemistry degree from Royal Holloway, University of London

Sector of Economy

Healthcare

Born

January 16, 1976 - 49 years ago

CEO of Apellis Pharmaceuticals, Inc. for

1 year 4 months (Jan 2024 - Present)

Previous Experience

Chief Commercial Officer at Apellis Pharmaceuticals, Inc.; Senior Vice President of Corporate Development at Biogen

Rivals

Competitors/colleagues of Adam Townsend

Holdings

See how much did Adam Townsend make over time.

Holdings and trades for CEO of Apellis Pharmaceuticals, Inc.

No data yet.

No data yet.

Total Stock Sold

$13.33M

APLS

$13.33M

219,106 APLS shares

What if they kept their stock?

If Adam Townsend didn't sell their stock, today they would have:
Extra APLS219,106 shares worth $7.03M.
This is -47.27% and $6.30M less than what they got when they sold the stock.

Insider Trading

See recent insider trades of Adam Townsend.

APLS

$20.52K

APLS at $29.52/share

Jan 29, 2025

Sale

APLS

$101.10K

APLS at $30.43/share

Jan 22, 2025

Sale

APLS

$65.94K

APLS at $29.96/share

Jan 17, 2025

Sale

APLS

$77.07K

APLS at $28.70/share

Jan 13, 2025

Sale

APLS

$77.80K

APLS at $67.77/share

Feb 12, 2024

Sale

APLS

$58.11K

APLS at $64.14/share

Jan 29, 2024

Sale

APLS

$221.83K

APLS at $65.00/share

Jan 22, 2024

Sale

APLS

$149.32K

APLS at $66.81/share

Jan 16, 2024

Sale

APLS

23,748 shares

APLS

Jan 16, 2024

Received

APLS

$6.70M

APLS at $60.90/share

Dec 1, 2023

Sale

Compensation History

See how much did Adam Townsend make over time.

No compensation data available for Adam Townsend yet. Come back soon!

Other Apellis Pharmaceuticals, Inc. CEOs

Here are other CEOs of Apellis Pharmaceuticals, Inc.